BRCA2 A902fs*2	Prostate Cancer	BRCA2 A902fs*2	Prostate Cancer	abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant: C4 – Case Studies abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant : C4	abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant: C4 – Case Studies abiraterone acetate + bicalutamide implant + leuprorelin depot Resistant : C4
BRCA2 A902fs*2	Prostate Cancer	BRCA2 A902fs*2	Prostate Cancer	cisplatin Sensitive: C4 – Case Studies cisplatin Sensitive : C4	cisplatin Sensitive: C4 – Case Studies cisplatin Sensitive : C4
BRCA2 A902fs*2	Prostate Cancer	BRCA2 A902fs*2	Prostate Cancer	docetaxel + cabazitaxel Resistant: C4 – Case Studies docetaxel + cabazitaxel Resistant : C4	docetaxel + cabazitaxel Resistant: C4 – Case Studies docetaxel + cabazitaxel Resistant : C4

BRCA2 A902fs*2

Associations